• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.人尿苷二磷酸葡萄糖醛酸基转移酶1A10的DQxD模体中的首个天冬氨酸在催化过程中与尿苷二磷酸葡萄糖醛酸相互作用。
Drug Metab Dispos. 2008 Mar;36(3):517-22. doi: 10.1124/dmd.107.016469. Epub 2007 Nov 29.
2
Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.UGT2B7 的精氨酸 259 赋予 UDP-糖选择性。
Mol Pharmacol. 2020 Dec;98(6):710-718. doi: 10.1124/molpharm.120.000104. Epub 2020 Oct 2.
3
Mapping the UDP-glucuronic acid binding site in UDP-glucuronosyltransferase-1A10 by homology-based modeling: confirmation with biochemical evidence.通过基于同源性的建模绘制UDP-葡萄糖醛酸转移酶-1A10中的UDP-葡萄糖醛酸结合位点:生化证据验证
Biochemistry. 2008 Jul 15;47(28):7385-92. doi: 10.1021/bi8006127. Epub 2008 Jun 21.
4
Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid.利用5-叠氮基-UDP-葡萄糖醛酸对人重组UDP-葡萄糖醛酸基转移酶UGT1*6进行光亲和标记研究。
Drug Metab Dispos. 1997 Apr;25(4):406-11.
5
Interaction of periodate-oxidized UDP-glucuronic acid with recombinant human liver UDP-glucuronosyltransferase 1A6.高碘酸盐氧化的UDP-葡萄糖醛酸与重组人肝UDP-葡萄糖醛酸基转移酶1A6的相互作用
Drug Metab Dispos. 1998 Aug;26(8):812-7.
6
The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues.人β1,3-葡糖醛酸基转移酶I对UDP-葡糖醛酸的供体底物特异性由两个关键的组氨酸和精氨酸残基决定。
J Biol Chem. 2002 Jul 12;277(28):25439-45. doi: 10.1074/jbc.M201912200. Epub 2002 May 1.
7
Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.吗啡的葡萄糖醛酸化和葡萄糖苷化代表互补的代谢途径,均由 UDP-葡糖醛酸基转移酶 2B7 催化:动力学、抑制和分子建模研究。
J Pharmacol Exp Ther. 2014 Apr;349(1):126-37. doi: 10.1124/jpet.113.212258. Epub 2014 Jan 23.
8
How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?高度同源的 UDP-葡糖醛酸基转移酶(UGT)1A9 和 UGT1A10 之间的活性差异有多大,是由多少个氨基酸造成的?
Drug Metab Dispos. 2010 Apr;38(4):687-96. doi: 10.1124/dmd.109.031229. Epub 2010 Jan 20.
9
Structural and functional studies of UDP-glucuronosyltransferases.尿苷二磷酸葡萄糖醛酸基转移酶的结构与功能研究
Drug Metab Rev. 1999 Nov;31(4):817-99. doi: 10.1081/dmr-100101944.
10
Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.人II相药物代谢酶尿苷二磷酸葡萄糖醛酸基转移酶2B7辅因子结合结构域的晶体结构
J Mol Biol. 2007 Jun 1;369(2):498-511. doi: 10.1016/j.jmb.2007.03.066. Epub 2007 Mar 30.

引用本文的文献

1
Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells.丹酚酸 B 通过抑制肝星状细胞中的神经酰胺葡萄糖基转移酶来抑制肝纤维化。
Acta Pharmacol Sin. 2023 Jun;44(6):1191-1205. doi: 10.1038/s41401-022-01044-9. Epub 2023 Jan 10.
2
Integrate thermostabilized fusion protein apocytochrome RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7.整合热稳定融合蛋白脱辅基细胞色素RIL和N-糖基化突变:人尿苷二磷酸葡萄糖醛酸基转移酶(UGT)2B7异源表达的新方法。
Front Pharmacol. 2022 Aug 12;13:965038. doi: 10.3389/fphar.2022.965038. eCollection 2022.
3
Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.人尿苷二磷酸葡糖醛酸转移酶在三氮唑吖啶酮和咪唑吖啶酮抗肿瘤剂 C-1305 和 C-1311 的生物转化中的作用:UGT1A10 的高度选择性底物。
Drug Metab Dispos. 2012 Sep;40(9):1736-43. doi: 10.1124/dmd.112.045401. Epub 2012 Jun 1.
4
Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.鉴定赋予 UDP-糖基转移酶 3A(UGT3A)酶糖选择性的残基。
J Biol Chem. 2012 Jul 13;287(29):24122-30. doi: 10.1074/jbc.M112.343608. Epub 2012 May 23.
5
Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.分析人肝微粒体和重组 UDP-葡糖醛酸基转移酶催化的 R-和 S-羟基华法林的葡糖醛酸化。
J Pharmacol Exp Ther. 2012 Jan;340(1):46-55. doi: 10.1124/jpet.111.184721. Epub 2011 Oct 4.
6
The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families.人 UDP-葡糖醛酸基转移酶 2B7 C 末端的晶体结构是人 UGT 中第一个被揭示的哺乳动物 UGT 靶标:对人 UGT1A 和 2B 家族均有意义。
Drug Metab Rev. 2010 Feb;42(1):133-44. doi: 10.3109/03602530903209049.
7
Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase.鉴定UDP糖基转移酶3A1为UDP-N-乙酰葡糖胺基转移酶。
J Biol Chem. 2008 Dec 26;283(52):36205-10. doi: 10.1074/jbc.M807961200. Epub 2008 Nov 3.

本文引用的文献

1
The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.人尿苷二磷酸葡萄糖醛酸基转移酶:核苷酸糖结合位点关键残基的鉴定
Mol Pharmacol. 2007 Sep;72(3):604-11. doi: 10.1124/mol.107.036871. Epub 2007 Jun 19.
2
Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.人II相药物代谢酶尿苷二磷酸葡萄糖醛酸基转移酶2B7辅因子结合结构域的晶体结构
J Mol Biol. 2007 Jun 1;369(2):498-511. doi: 10.1016/j.jmb.2007.03.066. Epub 2007 Mar 30.
3
Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification.一种类黄酮葡萄糖基转移酶的结构揭示了植物天然产物修饰的基础。
EMBO J. 2006 Mar 22;25(6):1396-405. doi: 10.1038/sj.emboj.7600970. Epub 2006 Feb 16.
4
Structures and mechanisms of glycosyltransferases.糖基转移酶的结构与机制。
Glycobiology. 2006 Feb;16(2):29R-37R. doi: 10.1093/glycob/cwj016. Epub 2005 Jul 21.
5
Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases.重组人尿苷二磷酸葡萄糖醛酸转移酶1A亚家族的动力学特性
Drug Metab Dispos. 2005 Jul;33(7):1017-26. doi: 10.1124/dmd.105.004093. Epub 2005 Mar 31.
6
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.人类尿苷二磷酸葡萄糖醛酸基转移酶:结构方面与药物葡萄糖醛酸化
Drug Metab Rev. 2003 Nov;35(4):287-303. doi: 10.1081/dmr-120026397.
7
Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.重组人尿苷二磷酸葡萄糖醛酸基转移酶对合成代谢雄激素类固醇的葡萄糖醛酸化作用。
Drug Metab Dispos. 2003 Sep;31(9):1117-24. doi: 10.1124/dmd.31.9.1117.
8
Opioids bind to the amino acids 84 to 118 of UDP-glucuronosyltransferase UGT2B7.阿片类药物与尿苷二磷酸葡萄糖醛酸基转移酶UGT2B7的84至118位氨基酸结合。
Mol Pharmacol. 2003 Feb;63(2):283-8. doi: 10.1124/mol.63.2.283.
9
Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme.重组人尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)的表达与特性。UGT1A9比其他UGTs对去污剂抑制更具抗性,并被纯化为一种活性二聚体酶。
J Biol Chem. 2003 Feb 7;278(6):3536-44. doi: 10.1074/jbc.M206136200. Epub 2002 Nov 14.
10
The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6.半胱氨酸126在人肝脏尿苷二磷酸葡萄糖醛酸基转移酶UGT1A6中的重要性。
Biochim Biophys Acta. 2002 May 20;1597(1):90-6. doi: 10.1016/s0167-4838(02)00266-2.

人尿苷二磷酸葡萄糖醛酸基转移酶1A10的DQxD模体中的首个天冬氨酸在催化过程中与尿苷二磷酸葡萄糖醛酸相互作用。

The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.

作者信息

Xiong Yan, Patana Anne-Sisko, Miley Michael J, Zielinska Agnieszka K, Bratton Stacie M, Miller Grover P, Goldman Adrian, Finel Moshe, Redinbo Matt R, Radominska-Pandya Anna

机构信息

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

出版信息

Drug Metab Dispos. 2008 Mar;36(3):517-22. doi: 10.1124/dmd.107.016469. Epub 2007 Nov 29.

DOI:10.1124/dmd.107.016469
PMID:18048489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2275115/
Abstract

All UDP-glucuronosyltransferase enzymes (UGTs) share a common cofactor, UDP-glucuronic acid (UDP-GlcUA). The binding site for UDP-GlcUA is localized to the C-terminal domain of UGTs on the basis of amino acid sequence homology analysis and crystal structures of glycosyltransferases, including the C-terminal domain of human UGT2B7. We hypothesized that the (393)DQMDNAK(399) region of human UGT1A10 interacts with the glucuronic acid moiety of UDP-GlcUA. Using site-directed mutagenesis and enzymatic analysis, we demonstrated that the D393A mutation abolished the glucuronidation activity of UGT1A10 toward all substrates. The effects of the alanine mutation at Q(394),D(396), and K(399) on glucuronidation activities were substrate-dependent. Previously, we examined the importance of these residues in UGT2B7. Although D(393) (D(398) in UGT2B7) is similarly critical for UDP-GlcUA binding in both enzymes, the effects of Q(394) (Q(399) in UGT2B7) to Ala mutation on activity were significant but different between UGT1A10 and UGT2B7. A model of the UDP-GlcUA binding site suggests that the contribution of other residues to cosubstrate binding may explain these differences between UGT1A10 and UGT2B7. We thus postulate that D(393) is critical for the binding of glucuronic acid and that proximal residues, e.g., Q(394) (Q(399) in UGT2B7), play a subtle role in cosubstrate binding in UGT1A10 and UGT2B7. Hence, this study provides important new information needed for the identification and understanding of the binding sites of UGTs, a major step forward in elucidating their molecular mechanism.

摘要

所有的尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)都共用一个共同的辅因子,即尿苷二磷酸葡萄糖醛酸(UDP-GlcUA)。基于氨基酸序列同源性分析以及糖基转移酶的晶体结构,包括人UGT2B7的C末端结构域,UDP-GlcUA的结合位点定位于UGTs的C末端结构域。我们推测人UGT1A10的(393)DQMDNAK(399)区域与UDP-GlcUA的葡萄糖醛酸部分相互作用。通过定点诱变和酶促分析,我们证明D393A突变消除了UGT1A10对所有底物的葡萄糖醛酸化活性。Q(394)、D(396)和K(399)处丙氨酸突变对葡萄糖醛酸化活性的影响取决于底物。此前,我们研究了这些残基在UGT2B7中的重要性。尽管D(393)(UGT2B7中的D(398))在两种酶中对UDP-GlcUA结合同样至关重要,但Q(394)(UGT2B7中的Q(399))突变为丙氨酸对活性的影响在UGT1A10和UGT2B7之间虽显著但有所不同。UDP-GlcUA结合位点的模型表明,其他残基对共底物结合的贡献可能解释了UGT1A10和UGT2B7之间的这些差异。因此,我们推测D(393)对葡萄糖醛酸的结合至关重要,而近端残基,例如Q(394)(UGT2B7中的Q(399)),在UGT1A10和UGT2B7的共底物结合中起微妙作用。因此,本研究为鉴定和理解UGTs的结合位点提供了重要的新信息,这是阐明其分子机制的重要一步。